文献速递系统性红斑狼疮

磷脂酸通过增强mTORC1信号促进狼疮中产生白介素-17A的双阴性T细胞生成

Phosphatidic Acid Promoting the Generation of Interleukin-17A Producing Double-Negative T Cells by Enhancing mTORC1 Signaling in Lupus.
PubMed 文献 · Arthritis Rheumatol · 2024-04-16

该研究探讨双阴性T(DNT)细胞在系统性红斑狼疮(SLE)发病中的作用及细胞内调控机制。在狼疮小鼠模型和SLE患者中DNT细胞显著增多,磷脂酸(PA)通过激活mTORC1通路促进产生IL-17A的DNT细胞扩增和IL-17A分泌,导致狼疮中GCB细胞异常。SLE患者循环DNT细胞比例升高与疾病活动度和蛋白尿相关。

要点

  • 狼疮小鼠模型和SLE患者中DNT细胞显著增多,且SLE患者循环DNT细胞比例与疾病活动度和蛋白尿相关。
  • PA通过增强mTORC1信号(上调p-S6)促进产生IL-17A的DNT细胞扩增和IL-17A分泌,雷帕霉素可剂量依赖性减少IL-17A水平和DNT细胞数量。
  • PA部分受磷脂酶D2调控,体外PA刺激可升高SLE患者DNT细胞的IL-17A分泌。

核心结论

  • T细胞中PA的积累可激活mTORC1通路,促进DNT细胞扩增和IL-17A分泌,导致狼疮中GCB细胞异常。

研究设计与样本

  • 研究采用狼疮小鼠模型、SLE患者和对照,用流式细胞术(FCM)检测DNT细胞,用FCM和定量聚合酶链反应检测mTOR通路信号,用液相色谱-电喷雾电离串联质谱检测脂质代谢物,并在DNT细胞培养中进行功能评估。
  • 将R848处理或溶剂对照处理的C57BL/6(B6)小鼠的DNT细胞与R848处理小鼠的B细胞共培养以探索功能。

主要发现

  • DNT细胞在自发性 and 诱导性小鼠狼疮模型及SLE患者中均显著增多。
  • 来自R848处理B6小鼠的扩增DNT细胞产生升高的IL-17A和IgG,并伴有生发中心B(GCB)细胞增加。
  • DNT细胞扩增与mTORC1通路激活相关,雷帕霉素处理使IL-17A水平和DNT细胞数量均呈剂量依赖性减少。
  • 脂质组学显示R848处理小鼠T细胞中脂质代谢物模式存在差异,候选代谢物中升高的PA部分受磷脂酶D2调控,可增加mTORC1下游靶点p-S6表达并正向扩增产生IL-17A的DNT细胞。
  • SLE患者循环DNT细胞比例升高与疾病活动度和蛋白尿相关,体外PA刺激后IL-17A分泌升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The goal was to investigate the role and intracellular regulatory mechanisms of double-negative T (DNT) cells in the pathogenesis of systemic lupus erythematosus (SLE). METHODS: DNT cells were assessed in murine models, patients with SLE, and controls using flow cytometry (FCM). DNT cells from either resiquimod (R848) or vehicle-treated C57BL/6 (B6) mice were cultured with B cells from R848-treated mice to explore functions. Differential mechanistic target of rapamycin (mTOR) pathway signaling in DNT cells measured using FCM and quantitative polymerase chain reaction was validated by rapamycin inhibition. Candidate lipid metabolites detected using liquid chromatography with electrospray ionization mass spectrometry/mass spectrometry were functionally assessed in DNT cell cultures. RESULTS: DNT cells were markedly increased in both spontaneous and induced mouse lupus models and in patients with SLE. Expanded DNT cells from R848-treated B6 mice produced elevated interleukin (IL)-17A and IgG with increased germinal center B (GCB) cells. Expansion of DNT cells associated with activation of mTORC1 pathway that both IL-17A levels and the number of DNT cells exhibited dose-dependent reduction with rapamycin treatment. Lipidomics studies revealed differential patterns of lipid metabolites in T cells of R848-treated mice. Among candidate metabolites, elevated phosphatidic acid (PA) that was partially controlled by phospholipase D2 increased the expression of the mTORC1 downstream target p-S6 and positively expanded IL-17A-producing DNT cells. Similarly, elevated proportions of circulating DNT cells in patients with SLE correlated with disease activity and proteinuria, and IL-17A secretion was elevated after in vitro PA stimulation. CONCLUSION: The accumulation of PA in T cells could activate the mTORC1 pathway, promoting DNT cell expansion and IL-17A secretion, resulting in GCB cell abnormalities in lupus.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Li W, Tang X, Zheng Y, et al. Phosphatidic Acid Promoting the Generation of Interleukin-17A Producing Double-Negative T Cells by Enhancing mTORC1 Signaling in Lupus. Arthritis Rheumatol. 2024. PMID: 38433594. doi:10.1002/art.42840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。